NuCana (NCNA) Enterprise Value (2015 - 2025)
NuCana (NCNA) reported Enterprise Value of -$32.3 million for Q4 2025, down 272.39% on a YoY basis from $18.7 million in Q4 2024, and up 5.32% sequentially from -$34.1 million in Q3 2025.
NuCana (NCNA) Enterprise Value (2015 - 2025) Analysis & Trends
NuCana (NCNA) has 11 years of Enterprise Value data on file, last reported at -$32.3 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 272.39% year-over-year to -$32.3 million; the trailing twelve-month figure through Dec 2025 stood at -$32.3 million (down 272.39% YoY), and the FY2025 full-year result was -$32.0 million, down 270.64% from the prior year.
- Enterprise Value improved to -$32.3 million in Q4 2025, from -$34.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$5.0 million in Q1 2025 to a low of -$108.4 million in Q1 2021.
- A 5-year average of -$44.1 million and a median of -$33.2 million in 2025 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 69.5% in 2025, while the deepest fall reached 272.39% in 2025.
- Tracing NCNA's Enterprise Value over 5 years: stood at -$81.2 million in 2021, then jumped by 39.49% to -$49.2 million in 2022, then soared by 56.51% to -$21.4 million in 2023, then soared by 59.48% to -$8.7 million in 2024, then tumbled by 272.39% to -$32.3 million in 2025.
- Business Quant data shows NCNA's Enterprise Value at -$32.3 million in Q4 2025, -$34.1 million in Q3 2025, and -$14.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | -3.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.26 Mn |
| Sep 30, 2025 | -34.07 Mn |
| Jun 30, 2025 | -14.74 Mn |
| Mar 31, 2025 | -4.98 Mn |
| Dec 31, 2024 | -8.66 Mn |
| Sep 30, 2024 | -14.75 Mn |
| Jun 30, 2024 | -14.69 Mn |
| Mar 31, 2024 | -16.32 Mn |
| Dec 31, 2023 | -21.38 Mn |
| Sep 30, 2023 | -22.55 Mn |
| Jun 30, 2023 | -30.84 Mn |
| Mar 31, 2023 | -37.68 Mn |
| Dec 31, 2022 | -49.16 Mn |
| Sep 30, 2022 | -59.81 Mn |
| Jun 30, 2022 | -58.59 Mn |
| Mar 31, 2022 | -70.53 Mn |
| Dec 31, 2021 | -81.24 Mn |
| Sep 30, 2021 | -97.92 Mn |
| Jun 30, 2021 | -102.62 Mn |
| Mar 31, 2021 | -108.42 Mn |